Arrowhead Pharmaceuticals (ARWR) Stock Chart & Stock Price History $14.73 -0.77 (-4.97%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$15.04 +0.31 (+2.07%) As of 03/25/2025 06:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Arrowhead Pharmaceuticals Stock Price Performance 5 Day Performance-2.51%1 Month Performance-24.58%3 Month Performance-24.96%6 Month Performance-24.15%Year-To-Date Performance-21.65%1 Year Performance-47.19% Receive ARWR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ARWR Stock Chart for Wednesday, March, 26, 2025 ARWR Chart by TradingViewRemove Ads Arrowhead Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/25/2025$15.50$14.73-4.97%$15.54$14.421.60 million shs$2.02 billion03/24/2025$14.80$15.50+4.73%$15.65$14.961.19 million shs$2.13 billion03/21/2025$15.11$14.80-2.05%$15.22$14.694.06 million shs$2.03 billion03/20/2025$15.47$15.11-2.33%$15.72$15.071.79 million shs$2.07 billion03/19/2025$15.10$15.47+2.45%$15.60$14.981.27 million shs$2.12 billion03/18/2025$15.60$15.10-3.21%$15.35$14.821.13 million shs$2.07 billion03/17/2025$15.36$15.60+1.56%$15.86$15.01831,497 shs$2.14 billion03/14/2025$15.07$15.36+1.92%$15.62$15.131.10 million shs$1.94 billion03/13/2025$15.77$15.07-4.44%$15.78$14.821.19 million shs$1.90 billion03/12/2025$15.06$15.77+4.71%$16.33$14.782.24 million shs$1.99 billion Get the Latest News and Ratings for ARWR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/11/2025$15.21$15.06-0.99%$15.56$14.232.03 million shs$1.90 billion03/10/2025$16.97$15.21-10.37%$16.87$15.112.11 million shs$1.92 billion03/07/2025$17.67$16.97-3.96%$17.58$16.841.35 million shs$2.14 billion03/06/2025$17.35$17.67+1.84%$17.79$16.831.17 million shs$2.23 billion03/05/2025$17.11$17.35+1.40%$17.41$16.571.43 million shs$2.19 billion03/04/2025$17.71$17.11-3.39%$17.48$16.572.50 million shs$2.16 billion03/03/2025$18.91$17.71-6.35%$18.97$17.611.64 million shs$2.23 billion02/28/2025$18.94$18.91-0.16%$19.04$18.531.22 million shs$2.38 billion02/27/2025$19.23$18.94-1.51%$19.97$18.911.04 million shs$2.39 billion02/26/2025$19.53$19.23-1.54%$19.98$19.081.13 million shs$2.42 billion02/25/2025$18.86$19.53+3.55%$19.82$18.481.65 million shs$2.46 billion02/24/2025$19.90$18.86-5.23%$19.89$18.581.37 million shs$2.38 billion Related Companies Roivant Sciences Stock Price Chart Revolution Medicines Stock Price Chart Legend Biotech Stock Price Chart Lantheus Stock Price Chart TG Therapeutics Stock Price Chart BridgeBio Pharma Stock Price Chart Axsome Therapeutics Stock Price Chart Telix Pharmaceuticals Limited American Depositary Shares Stock Price Chart Blueprint Medicines Stock Price Chart Grifols Stock Price Chart Receive ARWR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Arrowhead Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ARWR) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
